New chemo combo targets cancer belly fluid in early trial
Disease control
Recruiting now
This study tests a chemotherapy drug called liposomal irinotecan, given directly into the belly, for people with malignant ascites (fluid buildup from cancer) who have not responded to standard treatments. The trial has two phases: first, finding the safest dose, then testing if …
Phase: PHASE1, PHASE2 • Sponsor: Dong sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC